PROLONGED RECOMBINANT ACTIVATED FACTOR VII (rFVIIa) TREATMENT FOR SEVERE BLEEDING IN A FACTOR‐IX‐DEFICIENT PATIENT WITH AN INHIBITOR
- 1 July 1991
- journal article
- case report
- Published by Wiley in British Journal of Haematology
- Vol. 78 (3), 460-463
- https://doi.org/10.1111/j.1365-2141.1991.tb04468.x
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Use of recombinant activated factor VII for treatment of a retropharyngeal hemorrhage in a hemophilic patient with a high titer inhibitorAmerican Journal of Hematology, 1989
- Effect of recombinant factor VIIa on the hemostatic defect in dogs with hemophilia A, hemophilia B, and von Willebrand disease.Proceedings of the National Academy of Sciences, 1989
- SUCCESSFUL USE OF RECOMBINANT FACTOR VIIa IN PATIENT WITH SEVERE HAEMOPHILIA A DURING SYNOVECTOMYThe Lancet, 1988
- Amino acid sequence and posttranslational modifications of human factor VIIa from plasma and transfected baby hamster kidney cellsBiochemistry, 1988
- Measurement of Plasma Fibrin D-Dimer Levels with the Use of a Monoclonal Antibody Coupled to Latex BeadsAmerican Journal of Clinical Pathology, 1987
- Coagulopathy of disseminated neuroblastomaThe Journal of Pediatrics, 1983
- Use of human factor VIIa in the treatment of two hemophilia A patients with high-titer inhibitors.JCI Insight, 1983
- Factor VIII inhibitors: A clinical overviewAmerican Journal of Hematology, 1982
- Protein C Deficiency in a Dutch Family with Thrombotic DiseaseThrombosis and Haemostasis, 1982
- A More Uniform Measurement of Factor VIII InhibitorsThrombosis and Haemostasis, 1975